Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 82-89 , January 2007

Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in Adults

  • Karen K. Ballen

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence and reprint requests: Karen K. Ballen, MD, Division of Hematology/Oncology, Massachusetts General Hospital, Cox 640, 100 Blossom Street, Boston, MA 02114.
    • ,
  • Thomas R. Spitzer

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Beow Y. Yeap

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Steven McAfee

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Bimalangshu R. Dey

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Eyal Attar

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Richard Haspel

      Affiliations

    • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Grace Kao

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Deborah Liney

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Edwin Alyea

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Stephanie Lee

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Corey Cutler

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Vincent Ho

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Robert Soiffer

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Joseph H. Antin

      Affiliations

    • Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts

Received 10 May 2006 ,Accepted 29 August 2006.

References 

  1. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828–3832
  2. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–166
  3. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–1618
  4. Michel G, Rocha V, Chevret S, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood. 2003;102:4290–4297
  5. Ballen KK. New trends in umbilical cord blood transplantation. Blood. 2005;105:3786–3792
  6. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001;344:1815–1822
  7. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2003;9:772–780
  8. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
  9. Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–1919
  10. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–1347
  11. Verneris MR, Brunstein C, DeFor TE, et al. Risk of relapse after umbilical cord blood transplantation in patients with acute leukemia: marked reduction in recipients of two units. [abstract] Blood. 2005;106:305a
  12. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119–10122
  13. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828
  14. Schichman SA, Suess P, Vertino AM, et al. Comparison of short tandem repeat and variable-number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment. Bone Marrow Transplant. 2002;29:243–248
  15. Sykes M, Preffer F, McAfee S, et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation. Lancet. 1999;353:1755–1759
  16. Giralt S, Thall PF, Khouri I, et al. Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 2001;97:631–637
  17. Chakraverty R, Peggs K, Chopra R, et al. Limiting TRM following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood. 2002;99:1071–1078
  18. Koh LP, Chao NJ. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant. 2004;10:1–22
  19. Yuji K, Miyakoshi S, Kato D, et al. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. Biol Blood Marrow Transplant. 2005;11:314–318
  20. Locatelli F, Rocha V, Chastang C, et al. Eurocord Cord Blood Transplant Group Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662–3671
  21. Weinreb S, Delgado JC, Clavijo OP, et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant. 1998;22:193–196
  22. Ballen KK, Becker PS, Emmons RV, et al. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood. 2002;100:442–450
  23. Alyea EP, Kim TH, Ho V, et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood. 2005;105:1810–1814
  24. Brunstein CG, Weisdorf DJ, DeFor T, et al. Increased risk of Epstein-Barr virus–associated post-transplant lymphoproliferative disorder (EBV-PTLD) after anti-thymocyte globulin non-myeloablative conditioning for umbilical cord blood transplantation. [abstract] Blood. 2005;106:3235a
  25. Haspel RL, Kao GS, Yeap B, et al. Pre-infusion characteristics of the predominant cord blood unit correlate with hematopoietic engraftment in the setting of non- myeloablative double cord blood transplant. [abstract] Blood. 2005;106:3027a
  26. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature. 2003;425:841–846
  27. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med. 2005;201:1781–1791
  28. Nilsson SK, Johnson HM, Coverdale JA, et al. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood. 2001;97:2293–2299
  29. Barker JN, Scaradavou A, Stevens CE, et al. Analysis of 608 umbilical cord blood transplants (HLA match is a critical determinant of transplant-related mortality in the post-engraftment period even in the absence of graft-vs-host disease). [abstract] Blood. 2005;106:303a
  30. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation (HLA-C mismatching is associated with a strong adverse effect on transplantation outcome). Blood. 2004;104:1923–1930
  31. Ho VT, Kim HT, Liney D, et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;37:845–850
  32. Kogler G, Enczmann J, Rocha V, et al. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, and -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant. 2005;36:1033–1041

PII: S1083-8791(06)00606-9

doi: 10.1016/j.bbmt.2006.08.041

Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 82-89 , January 2007

Article Tools

* Image Usage & Resolution